Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |